Unknown Manufacturer
HCV-086 is a small molecule antiviral designed to block an enzyme required for the replication of the hepatitis C virus.
HCV-086 is a small molecule antiviral designed to block an enzyme required for the replication of the hepatitis C virus.
This drug inhibits polymerase enzyme which encourages hepatitis C virus (HCV) infections.
Investigated for use/treatment in hepatitis (viral, C).
One entry per invention. Patent families filed in the US, EP, WO and CN offices.
No patents found under this name
Patent documents usually refer to a drug by its chemical name or development code rather than its generic name, and applications are only published about 18 months after filing — so a newer drug may not appear here yet.
